Cargando…
Validity of patient-derived xenograft mouse models for lung cancer based on exome sequencing data
Patient-derived xenograft (PDX) mouse models are frequently used to test the drug efficacy in diverse types of cancer. They are known to recapitulate the patient characteristics faithfully, but a systematic survey with a large number of cases is yet missing in lung cancer. Here we report the compari...
Autores principales: | Kim, Jaewon, Rhee, Hwanseok, Kim, Jhingook, Lee, Sanghyuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Genome Organization
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120347/ https://www.ncbi.nlm.nih.gov/pubmed/32224836 http://dx.doi.org/10.5808/GI.2020.18.1.e3 |
Ejemplares similares
-
Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
por: Choi, Yunsik, et al.
Publicado: (2018) -
Characterization of TNNC1 as a Novel Tumor Suppressor of Lung Adenocarcinoma
por: Kim, Suyeon, et al.
Publicado: (2020) -
PDX models of human lung squamous cell carcinoma: consideration of factors in preclinical and co-clinical applications
por: Jung, Hae-Yun, et al.
Publicado: (2020) -
The use of whole exome sequencing and murine patient derived xenografts as a method of chemosensitivity testing in sarcoma
por: Calvert, Nicholas, et al.
Publicado: (2018) -
Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models
por: Shin, Ha-Yeon, et al.
Publicado: (2022)